長陽科技(688299.SH):擬投資12.24億元建年產8萬噸光學級聚酯基膜項目
格隆匯9月15日丨長陽科技(688299.SH)公佈,公司自設立以來,緊密圍繞國家發展戰略及相關產業政策,為更好地實現公司的發展戰略,促進公司生產規模擴大、產品結構進一步優化,持續推動公司轉型升級,打造冠軍級產品,公司擬通過全資子公司合肥長陽新材料科技有限公司(“合肥新材料”)投資122448萬元建設“年產8萬噸光學級聚酯基膜項目”。該項目產品主要應用方向為偏光片離型膜和保護膜、MLCC(多層陶瓷電容器)離型膜、新型顯示用預塗膜等光學級聚酯基膜。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.